Dermata Therapeutics, Inc. (DRMA) vs Imunon, Inc. (IMNN)
A side-by-side comparison of Dermata Therapeutics, Inc. and Imunon, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DRMA
Dermata Therapeutics, Inc.
$1.13HealthcareDelayed quote: Oct 6, 2026, 11:29 AM EDT
IMNN
Imunon, Inc.
$1.21HealthcareDelayed quote: Oct 6, 2026, 11:28 AM EDT
Total return — DRMA vs IMNN
growth of $100 · dividends reinvested · last 5yDRMA -100.0% (-84.5%/yr)IMNN -99.5% (-65.3%/yr)IMNN compounded faster over this window
Log scale — wide-divergence pair
DRMA IMNN
DRMA vs IMNN: by the numbers
- •IMNN is the larger company ($5M vs $5M market cap).
Metrics side by side
Valuation
| Metric | DRMA | IMNN |
|---|---|---|
| P/B ratio | 1.30 | 1.21 |
Profitability
| Metric | DRMA | IMNN |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -239.95% | -351.30% |
| ROIC | -246.61% | -126.69% |
Growth (annualized)
| Metric | DRMA | IMNN |
|---|---|---|
| Total return CAGR (5Y) | -83.90% | -63.83% |
Frequently asked
- How have DRMA and IMNN total returns compared?
- Over the past 5 years, DRMA delivered -83.90% and IMNN delivered -63.83% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.